The Conversation (0)
Stocks2Watch would like to invite the Investment Community to Optimi Health's Investor Day, Tuesday, April 5 at 1pm (PT) 4pm (ET). Individual investors, institutional investors, advisors, and analysts are invited to register now to attend the presentation.
REGISTER NOW AT: https://app.livestorm.co/stocks2watch/optimi-health-investor-day-april-5
Optimi Health Investor Day (CSE: OPTI) "Life-Changing Medicine, Supplied By Nature"
Tuesday, April 5 at 1:00pm (PDT) | 4:00pm (EDT) | 9:00pm (GMT)
Live Presentation by CEO Bill Ciprick & CMO Dane Stevens, followed by Q & A
In this presentation, Bill & Dane will discuss:
- Optimi Health Overview including Management, Facility, and Manufacturing Capabilities
- Health and Wellness Vision including Natural & Psychedelic Alternatives, Real-Life Benefits, Current Regulatory Environment
- Why Invest Now, Investment Thesis, Road Map to Success
Registration Open to Investors and Finance Professionals >>> This event is suitable for private investors, brokers, fund managers, financial institutions, funds, buy & sell side analysts, influencers, newsletter writers and journalists. The event is not suitable for people pursuing commercial opportunities.
REGISTER NOW AT: https://app.livestorm.co/stocks2watch/optimi-health-investor-day-april-5
ABOUT OPTIMI HEALTH (CSE: OPTI)
Optimi Health is developing a sophisticated mushroom brand that focuses on the health and wellness markets. With a vertically integrated approach, Optimi intends to cultivate, extract, process and distribute high quality functional mushroom products at its two facilities comprising a total of 20,000 square feet nearing completion in Princeton, British Columbia.
ABOUT STOCKS2WATCH
Stocks2Watch hosts online and in-person interactive events for publicly-traded companies to meet and present directly with investors. To learn more about Stocks2Watch and view a complete list of events, please visit www.stocks2watch.ca
CONTACT:
Neil Lock,
info@stocks2watch.ca
604-410-4888
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/118592
